Philip Morris International (PM)
(Delayed Data from NYSE)
$105.95 USD
+0.95 (0.90%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $105.85 -0.10 (-0.09%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$105.95 USD
+0.95 (0.90%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $105.85 -0.10 (-0.09%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth D Momentum D VGM
Zacks News
Altria (MO) Confirms Deal With JUUL, Unveils Savings Plan
by Zacks Equity Research
Altria's (MO) deal with JUUL to boost strength in reduced risk products realm. Further, the company reiterates earnings view for 2018.
Altria Likely to Invest in Juul to Bolster E-Cigarettes Unit
by Zacks Equity Research
Altria (MO) is undertaking efforts to boost smokeless offerings. Per market reports, the company is considering an investment in Juul.
Can Altria (MO) Rebound From a Terrible 2018?
by Zacks Equity Research
Stringent FDA regulations have led to fading cigarette sales that are plaguing the performance of Altria. Nevertheless, growth in RRPs looks encouraging.
Tobacco Industry Outlook: RRPs Could Drive Recovery
by Zacks Equity Research
Stringent FDA regulations have led to fading cigarette sales, plaguing the performance of most tobacco stocks. Nevertheless, reduced risk products are viewed as a viable growth platform.
Philip Morris (PM) Stock Moves -1.89%: What You Should Know
by Zacks Equity Research
Philip Morris (PM) closed the most recent trading day at $85.43, moving -1.89% from the previous trading session.
The Zacks Analyst Blog Highlights: JPMorgan, Procter & Gamble, UnitedHealth, McDonald's and Philip Morris
by Zacks Equity Research
The Zacks Analyst Blog Highlights: JPMorgan, Procter & Gamble, UnitedHealth, McDonald's and Philip Morris
Top Stock Reports for JPMorgan, Procter & Gamble and UnitedHealth
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan (JPM), Procter & Gamble (PG) and UnitedHealth (UNH)
Philip Morris (PM) Down 1.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Philip Morris (PM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Philip Morris (PM) closed at $86.33 in the latest trading session, marking a +0.58% move from the prior day.
Company News For Nov 13, 2018
by Zacks Equity Research
Companies In The News Are: ABMD,ISCA,SAP,PM
Philip Morris (PM) Stock Moves -0.35%: What You Should Know
by Zacks Equity Research
Philip Morris (PM) closed the most recent trading day at $89.17, moving -0.35% from the previous trading session.
ECigarette Company Juul Labs is Now Worth $15 Billion
by Madeleine Johnson
Juul is a booming e-cigarette company thanks to its popularity with teens and young adults.
Philip Morris (PM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Philip Morris (PM) closed at $88.35, marking a +0.32% move from the previous day.
The Zacks Analyst Blog Highlights: Procter & Gamble, Philip Morris, Honeywell, Lockheed and Illumina
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Procter & Gamble, Philip Morris, Honeywell, Lockheed and Illumina
Top Analyst Reports for Procter & Gamble, Philip Morris & Honeywell
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), Philip Morris (PM) and Honeywell (HON).
ETFs in Focus Post Philips Morris' Upbeat Earnings
by Zacks Equity Research
Philips Morris ETFs could experience some favorable price movement post strong Q3 results.
Will Pricing & Smokeless Unit Aid Altria's (MO) Q3 Earnings?
by Zacks Equity Research
Altria's (MO) Q3 performance to gain from strong pricing and strength in low risk alternatives. However, declining cigarette volumes is a concern.
Company News For Oct 19, 2018
by Zacks Equity Research
Companies in the news are: TXT, PM, SNA and AA
Trump vs. The Fed and PayPal, Intuitive Surgical Earnings Previews
by Ryan McQueeney
Ryan McQueeney discusses the Fed's decision to remain hawkish amid criticism from President Trump. He also recaps earnings results from Travelers, Blackstone, and Philip Morris. Later, he is joined by Dave Bartosiak to preview upcoming reports from PayPal and Intuitive Surgical.
Philip Morris (PM) Beats Q3 Earnings & Revenue Estimates
by Zacks Equity Research
Philip Morris's (PM) revenues in Q3 benefit from strong pricing and brands in the combustible category.
Philly Fed Survey, Jobless Claims & Earnings Data
by Zacks Equity Research
Philly Fed Survey, Jobless Claims & Earnings Data
Storm of Q3 Earnings Results: TRV, BX, PM & More
by Mark Vickery
Earnings reports from calendar Q3 are starting to come in heavier, like a storm of numbers raising the levels of investment discourse.
Philip Morris (PM) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Philip Morris (PM) delivered earnings and revenue surprises of 12.50% and 4.57%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Philip Morris (PM) Q3 Earnings: Cigarette Woes Dim Prospects
by Zacks Equity Research
Philip Morris' (PM) Q3 performance to be hurt by lower cigarette sales volumes. Nevertheless, performance of RRPs is expected to be strong.
Philip Morris (PM) Q3 Earnings Preview: Here's What to Look Out For
by Zacks Equity Research
Philip Morris (PM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.